Idifarma Receives Investment from Suanfarma S.A. to Boost International Growth
PTSM: Pharmaceutical Technology Sourcing and Management
As part of a planned process to replace venture-capital financial partners, Suanfarma S.A. has acquired a stake in Idifarma.
Idifarma, a Spanish CDMO, announced that it has received investment from Suanfarma S.A. to further its international growth plans. Established in 2001 as a small start-up business, Idifarma portfolio of services includes high-potency development and manufacturing and spray drying to solve solubility challenges. The CDMO has more than 100 pharmaceutical clients.
As part of a planned process to replace venture-capital financial partners, Suanfarma S.A. has acquired a stake in the CDMO. The company has been supplying raw materials to the pharmaceutical industry for more than 20 years.
Suanfarma S.A. acquired shares from three venture capital firms, while the co-founders of Idifarma remain as shareholders and in executive positions. Two local financial investors (Sodena and Caja Rural de Navarra), which have funded the company since its inception, will also remain as shareholders to provide stability to the CDMO in this new phase of growth.
Source: Idifarma
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
